Estados financieros detallados de Lexaria Bioscience Corp. (LEXX): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Lexaria Bioscience Corp. registró ingresos de $705923 en el último ejercicio fiscal, con un CAGR de 5 años del 12.9%.
Márgenes de los últimos 12 meses: margen bruto 100.0%, margen operativo -39.7%, margen neto -39.9%.
Al precio actual de $3.10, LEXX presenta beneficios negativos (P/E no significativo) y un ROE del -160.72%. La capitalización bursátil es de $5M.
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Ingresos | $40718 | $63639 | $433287 | $222610 | $384543 | $722738 | $255397 | $226208 | $464278 | $705923 |
| Coste de Ventas | $45615 | $29750 | $25185 | $22893 | $99378 | $175346 | $71841 | $31500 | $4822 | $2720 |
| Beneficio Bruto | -$4897 | $33889 | $408102 | $199717 | $215415 | $547392 | $183556 | $194708 | $459456 | $703203 |
| I+D | $9024 | $54185 | $492864 | $555730 | $387074 | $1.3M | $1.8M | $3.7M | $2.4M | $8.2M |
| Generales y Administrativos | $1.2M | $1.8M | $6.5M | $3.6M | $4.0M | $5.0M | $5.0M | $3.1M | $3.9M | $4.3M |
| Gastos Operativos | $1.2M | $1.9M | $7.0M | $4.3M | $4.4M | $6.2M | $6.8M | $6.7M | $6.2M | $12.6M |
| Beneficio Operativo | -$1.2M | -$1.9M | -$6.6M | -$4.1M | -$4.1M | -$5.7M | -$6.6M | -$6.5M | -$5.8M | -$11.9M |
| EBITDA | -$1.3M | -$1.9M | -$6.6M | -$4.0M | -$4.0M | -$4.0M | -$7.3M | -$6.6M | -$5.7M | -$11.8M |
| Gastos por Intereses | $2250 | $6015 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Antes de Impuestos | -$1.3M | -$1.9M | -$6.6M | -$4.2M | -$4.1M | -$4.2M | -$7.4M | -$6.7M | -$5.8M | -$11.9M |
| Impuestos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$1.2M | -$1.9M | -$6.6M | -$4.1M | -$3.9M | -$4.0M | -$7.3M | -$6.7M | -$5.8M | -$11.9M |
| BPA | $-12.45 | $-14.25 | $-41.85 | $-24.30 | $-21.30 | $-13.80 | $-18.60 | $-15.15 | $-7.05 | $-9.90 |
| BPA Diluido | $-12.45 | $-14.25 | $-41.85 | $-24.30 | $-21.30 | $-13.80 | $-18.60 | $-15.15 | $-7.05 | $-9.90 |
| Acciones en Circulación (Diluidas) | $97422 | $130589 | $157688 | $172870 | $184892 | $292763 | $392350 | $440938 | $825598 | $1.2M |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Ingresos | $174000 | 0 | $20000 | 0 |
| Beneficio Bruto | $174000 | 0 | $20000 | 0 |
| Beneficio Operativo | -$2.7M | -$1.6M | -$1.5M | -$2.0M |
| EBITDA | -$2.7M | -$1.6M | -$1.4M | -$2.0M |
| Beneficio Neto | -$2.7M | -$1.6M | -$1.4M | -$2.0M |
| BPA | $-2.10 | $-1.12 | $-0.90 | $-1.20 |
| BPA Diluido | $-2.10 | $-1.12 | $-0.90 | $-1.20 |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caja y Equivalentes | $93409 | $2.5M | $1.7M | $1.3M | $1.3M | $10.9M | $5.8M | $1.4M | $6.5M | $1.8M |
| Inversiones a Corto | 0 | 0 | $10151 | $64214 | $19321 | $833841 | $347335 | $125642 | $55807 | $165360 |
| Cuentas por Cobrar | $131083 | $45293 | $265751 | $273145 | $313925 | $342401 | $201784 | $175245 | $154477 | $174000 |
| Inventario | $134724 | $67174 | $87233 | $127396 | $116871 | $29648 | $38418 | 0 | 0 | 0 |
| Activos Corrientes | $510166 | $2.8M | $2.3M | $1.8M | $1.9M | $12.4M | $7.0M | $2.2M | $7.9M | $3.5M |
| Inmovilizado Material | $2475 | $1856 | $1237 | $591263 | $610277 | $459254 | $367949 | $421589 | $389552 | $334945 |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | $53997 | $62827 | $146538 | $265127 | $292000 | $364623 | $488462 | $462625 | $516676 | $307818 |
| Activos Totales | $566638 | $2.9M | $2.4M | $2.7M | $2.8M | $13.3M | $7.8M | $3.1M | $8.9M | $4.2M |
| Cuentas por Pagar | $90010 | $32574 | $14378 | $31463 | $45080 | $104891 | $120146 | $225038 | $1.1M | $1.4M |
| Deuda a Corto | 0 | 0 | 0 | 0 | 0 | $7926 | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $433881 | $92347 | $43640 | $184507 | $225917 | $153276 | $194036 | $267735 | $1.1M | $1.5M |
| Deuda a Largo | $45000 | 0 | 0 | 0 | $30670 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $478881 | $92347 | $43640 | $184507 | $345980 | $203265 | $201437 | $403908 | $1.2M | $1.6M |
| Reservas | -$11.3M | -$13.2M | -$19.8M | -$23.9M | -$27.8M | -$31.8M | -$39.1M | -$45.8M | -$51.6M | -$63.5M |
| Patrimonio Neto | $266045 | $3.0M | $2.4M | $2.4M | $2.5M | $13.3M | $7.9M | $3.0M | $8.0M | $3.0M |
| Deuda Total | $45000 | $42690 | $7855 | 0 | $156101 | $97319 | $49988 | $163967 | $137366 | $109320 |
| Deuda Neta | -$48409 | -$2.5M | -$1.7M | -$1.3M | -$1.2M | -$11.7M | -$6.1M | -$1.3M | -$6.4M | -$1.9M |
| Capital Circulante | $76285 | $2.7M | $2.2M | $1.6M | $1.7M | $12.3M | $6.8M | $1.9M | $6.8M | $2.0M |
Balance (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caja y Equivalentes | $1.8M | $4.3M | $5.1M | $3.5M |
| Activos Totales | $4.2M | $6.1M | $6.5M | $4.8M |
| Pasivos Totales | $1.6M | $1.5M | $276997 | $437091 |
| Patrimonio Neto | $3.0M | $4.9M | $6.6M | $4.7M |
| Deuda Total | $109320 | $101920 | $94386 | $86714 |
Flujo de Caja (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Beneficio Neto | -$1.3M | -$1.9M | -$6.6M | -$4.2M | -$4.1M | -$4.2M | -$7.4M | -$6.7M | -$5.8M | -$11.9M |
| Amortizaciones | $619 | $1488 | $2307 | $60550 | $146092 | $147597 | $102718 | $145397 | $76153 | $87825 |
| Compensación en Acciones | $122015 | $113044 | $2.6M | $626692 | $1.1M | $410007 | $752591 | $170382 | $492236 | $859494 |
| Cambio en Capital Circulante | $337967 | -$301122 | -$371232 | $79683 | -$194363 | $63526 | -$351475 | $143264 | $106556 | $195576 |
| Flujo de Caja Operativo | -$660856 | -$1.5M | -$2.5M | -$3.0M | -$2.6M | -$4.0M | -$4.9M | -$5.9M | -$5.0M | -$10.5M |
| Inversiones (CapEx) | -$20102 | -$9699 | -$85399 | -$769165 | -$33645 | -$79493 | -$49191 | -$169610 | -$43017 | -$24643 |
| Adquisiciones | 0 | 0 | -$70000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$680958 | -$1.6M | -$2.6M | -$3.8M | -$2.7M | -$4.1M | -$4.9M | -$6.1M | -$5.0M | -$10.5M |
Flujo de Caja (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Flujo de Caja Operativo | -$2.6M | -$984098 | -$2.2M | -$1.6M |
| Inversiones (CapEx) | -$14611 | -$5099 | -$55910 | -$26252 |
| Flujo de Caja Libre | -$2.7M | -$989197 | -$2.2M | -$1.7M |
| Dividendos Pagados | 0 | 0 | 0 | 0 |
| Compensación en Acciones | $122724 | $74895 | $74895 | $92944 |
Crecimiento y Márgenes (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crecimiento Ingresos (anual) | | +56.3% | +580.9% | -48.6% | +72.7% | +87.9% | -64.7% | -11.4% | +105.2% | +52.0% |
| Crecimiento Beneficio Neto (anual) | | -53.9% | -253.0% | +37.9% | +4.0% | -2.4% | -80.5% | +8.3% | +13.0% | -105.4% |
| Crecimiento BPA (anual) | | -14.5% | -193.7% | +41.9% | +12.3% | +35.2% | -34.8% | +18.5% | +53.5% | -40.4% |
| Cambio en Acciones (anual) | | +34.0% | +20.8% | +9.6% | +7.0% | +58.3% | +34.0% | +12.4% | +87.2% | +45.3% |
| Crecimiento FCF (anual) | | -128.4% | -67.4% | -45.0% | +29.7% | -53.4% | -21.1% | -22.8% | +17.3% | -109.4% |
| Margen Bruto | -12.0% | 53.3% | 94.2% | 89.7% | 56.0% | 75.7% | 71.9% | 86.1% | 99.0% | 99.6% |
| Margen Operativo | -3023.1% | -2914.6% | -1523.3% | -1823.7% | -1078.9% | -786.8% | -2591.7% | -2888.5% | -1239.2% | -1683.0% |
| Margen EBITDA | -3129.8% | -3020.1% | -1522.8% | -1796.5% | -1040.9% | -555.7% | -2850.8% | -2903.1% | -1234.7% | -1674.9% |
| Margen Neto | -2983.4% | -2937.3% | -1523.0% | -1841.5% | -1023.0% | -557.2% | -2846.3% | -2946.4% | -1248.2% | -1686.0% |
| Margen FCF | -1672.4% | -2444.4% | -600.8% | -1695.7% | -689.8% | -563.0% | -1929.8% | -2674.9% | -1077.4% | -1483.9% |
| Tasa Impositiva Efectiva | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% |
Datos por Acción (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Acción | $-6.99 | $-11.91 | $-16.51 | $-21.84 | $-14.35 | $-13.90 | $-12.56 | $-13.72 | $-6.06 | $-8.73 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $97422 | $130589 | $157688 | $172870 | $184892 | $292763 | $392350 | $440938 | $825598 | $1.2M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -160.72% |
| Rentabilidad sobre capital invertido | -173.96% |
| Rentabilidad sobre activos | -161.71% |
| Margen bruto | 100.00% |
| Margen operativo | -3973.16% |
| Margen neto | -3985.58% |
Salud financiera
| Deuda / Patrimonio | 0.02 |
| Ratio corriente | 10.60 |
| Piotroski F-Score | 3 |
| Altman Z-Score | -23.89 |
Ratios Clave (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/E | -5.40 | -4.72 | -1.61 | -2.77 | -3.15 | -6.76 | -2.39 | -1.04 | -8.32 | -1.33 |
| P/VC | 24.61 | 2.92 | 4.44 | 4.87 | 4.92 | 2.06 | 2.19 | 2.28 | 6.03 | 5.30 |
| P/V | 160.78 | 137.90 | 24.46 | 52.18 | 32.31 | 37.79 | 68.21 | 30.70 | 104.29 | 22.44 |
| Margen Bruto | -12.0% | 53.3% | 94.2% | 89.7% | 56.0% | 75.7% | 71.9% | 86.1% | 99.0% | 99.6% |
| Margen Operativo | -3023.1% | -2914.6% | -1523.3% | -1823.7% | -1078.9% | -786.8% | -2591.7% | -2888.5% | -1239.2% | -1683.0% |
| Margen Neto | -2983.4% | -2937.3% | -1523.0% | -1841.5% | -1023.0% | -557.2% | -2846.3% | -2946.4% | -1248.2% | -1686.0% |